Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions

doi:10.3748/wjg.v24.i11.1228

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8922)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

567

WORD

198

HTML

4625

Figures (1-5)

268

Tables (1-4)

232

Sum=5890

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1183

Download

1849

Sum=3032

Mar 21, 2018 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Mar 21, 2018; 24(11): 1228-1238
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1228

Full Size Figure Download Figure

Figure 3 Balance between active and inactive natural killer cells, plasmacytoid cells, and myeloid dendritic cells in hepatocellular carcinoma patients in relation to the normal group. ^aP < 0.05. HCC: Hepatocellular carcinoma; mDCs: Myeloid dendritic cells; NK: Natural killer; pDCs: Plasmacytoid cells.

Citation: Zekri ARN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gastroenterol 2018; 24(11): 1228-1238
URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1228.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1228